Search Medical Condition
Please enter condition
Please choose location

Ningbo, China Clinical Trials

A listing of Ningbo, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (13) clinical trials

PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor

A total of 20 patients may be enrolled over a period of 1-2 years.

Phase

0.0 miles

Learn More »

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer

A total of 40 patients may be enrolled over a period of 1-2 years.

Phase

0.0 miles

Learn More »

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

A total of 40 patients may be enrolled over a period of 1-2 years.

Phase

0.0 miles

Learn More »

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

A total of 40 patients may be enrolled over a period of 1-2 years.

Phase

0.0 miles

Learn More »

Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency

To evaluate the safety and efficacy of PEG Somatropin Injection (Jintrolong®) in the treatment of short stature due to endogenous growth hormone deficiency (GHD) in the broad of population of children.

Phase

0.0 miles

Learn More »

REALM China Extension Study

The purpose of this study is to conduct an investigator initiated observational study to continue to follow up the China subset of study participants for another 5 years after they complete participation in the REALM Study

Phase N/A

0.0 miles

Learn More »

PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies

This is a single-arm, open-label, one center, dose escalation clinical study, to determine the safety and efficacy of infusion of autologous T cells engineered to express immune checkpoint antibody and chimeric antigen receptor targeting mesothelin in adult patients with mesothelin positive, recurrent or refractory malignant tumors.

Phase

0.0 miles

Learn More »

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China

In the study, 500 advanced NSCLC patients will be recruited. All the patients will receive biopsy genotype assay and circultating tumor DNA (ctDNA) liquid biopsy. Patients who carry actionable EGFR mutation, ROS1 fusion, ALK fusion or MET exon 14 skipping mutation will receive TKI treatment according to guidelines. During the ...

Phase N/A

0.0 miles

Learn More »

Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting

The study is to verify atorvastatin effectiveness and safety in Chinese population, and explore the optimal atorvastatin regimens in high-to-moderate risk for ASCVD。

Phase N/A

0.82 miles

Learn More »

A Phase / Seamless Study to Evaluate Efficacy and Safety of Paracetamol Injection as Adjuvant to Morphine-based Postoperative Analgesia

Paracetamol,a classical analgesic agent,constitutes an essential component of multi-modal analgesia. This medication is generally safe, well tolerated and effective within recommended daily dose.The purpose of the study is to evaluate the efficacy and safety of Paracetamol Injection as adjuvant to morphine-based post-operative analgesia, as well as to explore the reasonable ...

Phase

0.82 miles

Learn More »